This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PFKM Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PFKM WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~85.2 kDa | |
| Observed band | ~85 kDa | |
| Gel | 5–20% (catalog A00437-2) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 3 isoform(s) |
The A00437-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human HepG2, human 293T (catalog A00437-2) |
| Gel % | 5–20% (catalog A00437-2) |
| Load | 30 ug; reducing conditions (catalog A00437-2) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A00437-2) |
| Membrane | nitrocellulose membrane (catalog A00437-2) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A00437-2) |
| Primary antibody | A00437-2 · 0.5 μg/mL (catalog A00437-2) |
| Primary incubation | overnight at 4°C (catalog A00437-2) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A00437-2) |
| Secondary incubation | 1.5 hour at RT (catalog A00437-2) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A00437-2) |
| Detection | ECL (catalog A00437-2) |
PFKM is predicted at 85.2 kDa and observed at ~85 kDa; the cause of the small difference is not established.
| Band at ~85 kDa | Matches the empirical PFKM band and is close to the 85.2 kDa prediction. |
| Single sharp band near 85 kDa | Consistent with PFKM without a resolved modification or isoform shift. |
| Several bands near the expected region | Could reflect isoforms 1, 2, and 3; their migration differences are unestablished. |
| No separate glycosylated band | O-linked GlcNAc at Ser530 does not necessarily produce a visible shift. |
| Predicted 85.2 kDa mass | Corresponds closely to the observed ~85 kDa band. |
| O-linked GlcNAc at Ser530 | May affect mobility, but a visible shift is not established. |
| Splice isoform 1 | Its relative size and migration versus the other isoforms are unspecified. |
| Splice isoform 2 | Its relative size and migration versus the other isoforms are unspecified. |
| Splice isoform 3 | Its relative size and migration versus the other isoforms are unspecified. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Cytoplasmic PFKM may be below detection in the tested lysate. | Check loading and antibody performance with a positive lysate. |
| Band higher than expected | The listed features do not establish a higher-migrating PFKM band. | Check specificity with knockdown or an independent antibody. |
| Band lower than expected | An isoform is possible, but its migration is unspecified. | Confirm identity with knockdown or an independent antibody. |
| Multiple bands | Isoforms 1, 2, and 3 are listed, but distinct bands are unverified. | Compare bands after PFKM knockdown. |
| Weak or no signal | PFKM signal may be below detection in the tested sample. | Check protein loading and include a positive lysate. |
| Fragments below expected size | Sample degradation may produce smaller reactive fragments. | Prepare fresh lysate with protease inhibitors and confirm band identity. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Caudate | neuronal cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Esophagus | squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Oral mucosa | squamous epithelial cells | Low | Protein (IHC) | HPA → |
| Breast | glandular cells | Medium | Protein (IHC) | HPA → |
| Cervix | squamous epithelial cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PFKM, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Both listed anti-PFKM antibodies have Western blot images using human cell lysates and rat and mouse tissues. A00437-2 shows an approximately 85 kDa band; M04370-1 shows approximately 81 kDa, compared with the stated 85 kDa expectation.
Which to pick: Match the pictured samples to your experiment: A00437-2 includes HeLa, HepG2, 293T, U-87MG, and rodent heart; M04370-1 includes HeLa, MCF-7, SH-SY5Y, and rodent heart and brain. Both list human, mouse, and rat reactivity.